Skip to main content
Medical information Clinical review pending

Genetic Testing

Achondroplasia FGFR3 Full Gene Sequence Analysis

The Achondroplasia FGFR3 Full Gene Sequence Analysis is a genetic test that identifies mutations in the FGFR3 gene, the most common cause of achondroplasia, a form of dwarfism. This test helps understand genetic risks and aids in family planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Peripheral blood, amniotic fluid, chorionic villi, or cord blood.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. A Doctor’s prescription is required for this test.
Test priceKSh 60,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Achondroplasia FGFR3 Full Gene Sequence Analysis test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals exhibiting symptoms suggestive of achondroplasia.
  • ✓Family history of achondroplasia.
  • ✓Prenatal diagnosis for couples at risk.
  • ✓Genetic counseling for individuals or families affected by achondroplasia.
  • ✓Confirmation of diagnosis in ambiguous cases.
02

In plain language

What this test helps you understand

This test helps confirm a diagnosis of achondroplasia, identify the specific mutation in the FGFR3 gene, and assess the risk of recurrence in future pregnancies. It provides valuable information for genetic counseling and family planning.
The Achondroplasia FGFR3 Full Gene Sequence Analysis is a specialized genetic test designed to detect mutations within the FGFR3 gene. This gene is known to be responsible for achondroplasia, the most prevalent form of dwarfism. Understanding the genetic basis of this condition is vital for individuals and families affected by it. This test provides crucial information for diagnosis and genetic counseling. It is particularly important for those considering family planning or seeking to understand the genetic factors contributing to dwarfism. The analysis involves examining the entire sequence of the FGFR3 gene to identify specific changes linked to achondroplasia. This comprehensive approach ensures accurate detection of mutations. The results can help confirm a diagnosis, assess the risk of passing the condition to offspring, and guide medical management.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. A Doctor’s prescription is required for this test.
SamplePeripheral blood, amniotic fluid, chorionic villi, or cord blood.
MethodologyFull gene sequencing of the FGFR3 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes the FGFR3 gene specifically. It may not detect mutations in other genes that could cause similar conditions. Results should be interpreted in the context of clinical findings and family history.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Achondroplasia is the most common form of dwarfism, a genetic condition affecting bone growth, resulting in shorter limbs.
Individuals with symptoms of achondroplasia, those with a family history of the condition, or couples planning a family who are concerned about the risk should consider this test.
The test involves analyzing the DNA sequence of the FGFR3 gene using a sample like blood or amniotic fluid.
Confirm with the laboratory before booking.
Results will be discussed with your doctor or a genetic counselor to understand their implications for your health and family planning.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp